TURUNÇ Advises BioScience Managers on its Fund Formation

22 January 2026
Kerem Turunç
1896

TURUNÇ has advised BioScience Managers on obtaining an approval from the Turkish Capital Markets Board for its inaugural Turkish fund. The fund, which will be co-managed by Maxis, is the first healthcare-focused Turkish fund backed by foreign investors.

BioScience Managers is an international healthcare investment firm that finances and enables innovative science and technology poised to transform healthcare.

The TURUNÇ team included Kerem Turunç and Naz Esen.

Please see here for more information.